
Pharming Group N.V. PHAR
€ 14.53
-5.17%
Geschäftsbericht 2024
hinzugefügt 13.12.2025
Pharming Group N.V. EV/EBITDA 2011-2025 | PHAR
EV/EBITDA Jährlich Pharming Group N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 12.8 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12.8 | 12.8 | 12.8 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
-3.41 | $ 4.86 | 3.08 % | $ 807 M | ||
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
-9.24 | $ 3.22 | -1.08 % | $ 249 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-2.13 | $ 1.05 | -7.08 % | $ 290 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 0.27 | -4.88 % | $ 588 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Catalyst Biosciences
CBIO
|
0.34 | $ 13.58 | -3.62 % | $ 894 M | ||
|
Ascendis Pharma A/S
ASND
|
-15.7 | $ 216.09 | -1.96 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.14 | -4.15 % | $ 7.55 B | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 27.1 | -1.51 % | $ 1.75 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
17.3 | $ 88.16 | 0.19 % | $ 9.1 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 24.27 | 2.75 % | $ 2.87 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
CureVac N.V.
CVAC
|
-7.74 | $ 5.02 | -0.59 % | $ 934 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
BioVie
BIVI
|
-0.244 | $ 1.4 | -3.45 % | $ 2.07 M | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 93.87 | -0.99 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Dynavax Technologies Corporation
DVAX
|
12.8 | $ 10.8 | - | $ 1.4 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 26.2 | 3.68 % | $ 1.27 B | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
38.7 | $ 9.57 | 0.1 % | $ 140 M | ||
|
Eton Pharmaceuticals
ETON
|
-53 | $ 15.96 | -4.42 % | $ 409 M | ||
|
Evogene Ltd.
EVGN
|
-1.31 | $ 1.07 | -0.51 % | $ 27.9 M | ||
|
Exelixis
EXEL
|
18.1 | $ 41.43 | 1.35 % | $ 12 B | ||
|
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
-63.9 | $ 548.8 | -2.74 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Foghorn Therapeutics
FHTX
|
-11.7 | $ 4.36 | -1.8 % | $ 239 M | ||
|
Aytu BioScience
AYTU
|
-1.92 | $ 2.39 | 3.91 % | $ 15 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | $ 91.03 | 1.34 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 11.36 | -1.47 % | $ 735 M | ||
|
Biogen
BIIB
|
12.7 | $ 174.34 | 0.14 % | $ 25.4 B |